Le Lézard
Classified in: Health
Subject: AWD

George Michael Varkarakis, MD is recognized by Continental Who's Who in the field of Medicine as a Plastic & Reconstructive Surgeon at his Private Practice


MIAMI, Feb. 22, 2019 /PRNewswire/ -- George Michael Varkarakis, MD is recognized by Continental Who's Who in the field of Medicine as a Plastic & Reconstructive Surgeon at his Private Practice.   

With over 21 years of experience in his field, Dr. George M. Varkarakis is an award-winning Plastic Surgeon in Miami, Florida.  He is an active editorial board member and peer-reviewer for key medical journals.  Utilizing a wide range of surgical and non-surgical treatments of the face, breast, and body, Dr. Varkarakis specializes in Facelifts, Browlifts with eyelid surgery, Fat grafting, Skin cancer reconstruction, Bone and soft tissue reconstruction, Regeneration of stem cells, and craniofacial plastic surgery.

Throughout his education and training, Dr. Varkarakis graduated from the University of Athens and is board certified in Plastic Surgery and Craniofacial Surgery.

To further his professional development, Dr. Varkarakis is affiliated with the American Society of Plastic and Maxillofacial Surgeons. 

For more information, please visit www.gvplasticsurgery.com.

Contact: Katherine Green, 516-825-5634, [email protected]

SOURCE Continental Who's Who


These press releases may also interest you

at 16:30
Catalent, Inc. ("Catalent"), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial results for the third quarter of fiscal 2024, which ended March 31, 2024. "I am pleased to report...

at 16:23
Children's Minnesota is proud to announce it has been re-designated as an "LGBTQ+ Healthcare Equality Leader" by the Human Rights Campaign Foundation (HRC). The designation was awarded in the 16th iteration of HRC's Healthcare Equality Index (HEI),...

at 16:20
Innoviva, Inc. ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic...

at 16:15
enVVeno Medical Corporation ("enVVeno" or the "Company"), a...

at 16:10
Prothena Corporation plc , a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported financial results for the first quarter of 2024 and provided...

at 16:10
Myomo, Inc. ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended...



News published on and distributed by: